Free-to-view webinar 'Constipation in children and young people: implementing the NICE quality standard'
MGP, the publisher of Guidelines and Guidelines in Practice has produced free-to-view webinars for healthcare professionals to help them keep up to date with best practice and maintain their guideline-related learning.
Constipation in children and young people: implementing the NICE quality standard
The webinar will be presented by Dr Hasan Chowhan and Lynne Watson on Wednesday 22nd October, 2 - 3pm and will:
- Discuss the NICE quality standard on constipation in children and young people
- Provide a GP perspective on implementing best practice
Food & Function Clinical Research Group
Do you have an interest in any or all of the following areas: small bowel, nutrition, pancreas, neurogastroenterology, motility, or functional GI disorders?
The BSG Research Committee and the SBN, NGM and Pancreas Sections are seeking nominations of BSG members for membership of a new Clinical Research Group (CRG), called the Food & Function CRG. It will consist of a steering group of 10 people with these interests representing a variety of regions within the UK, who will be charged with fostering collaborative research within the UK. The posts will be for 3 years. Nine of the 10 elected members will hold a consultant post (or equivalent); the tenth will be a Trainee member in one of these Sections. Other roles will be co-opted to the Group once the actual composition is known. It is expected that the consultant applicants will normally have a higher degree and or other relevant experience.
Nominations should include a CV and one-paragraph personal statement by the nominee/applicant regarding their interest in the role. Nominations should be made with the express agreement of the nominee. Applicants /nominees are requested to indicate whether they would be willing to chair the Committee, if elected. To download the terms of reference for the CRGs, please click here.
Only members of the NGM, SBN and Pancreas Sections of the BSG (including Trainees) are eligible to run for election and to vote in the election, which will take place in January 2015.
Best Wishes, John McLaughlin – Chair, BSG Research Committee
Lancet liver recommendations must be implemented to address crisis
The British Society of Gastroenterology (BSG) has today urged for the Lancet Commission UK Liver Disease Publication recommendations to be pursued "without delay" to "address the UK liver disease crisis".
Liver Disease mortality rates have increased by 400% since 1970 and is the third most common form of premature death in the UK.
The most common form of liver disease is alcohol-related, followed by fatty liver disease caused by obesity. The steep rise in both alcohol consumption and obesity in recent decades has led to increases in both conditions.
Incidences of chronic viral hepatitis are also on the rise, with annual deaths from hepatitis C having quadrupled since 1996, and significant increases in hepatitis B infection.
The Lancet report calls for wide-reaching, joined-up action including:
- Better detection of early disease in primary care
- Improved support services in community settings
- The establishment of Liver Units in District General Hospitals
- A national review of liver transplantation services
- Strengthening of continuity of care for children with liver disease surviving into adult life
- A range of population-level measures such as a minimum unit price for alcohol
- Promotion of healthier lifestyles with clearer government messaging and new regulations on the food industry
- Eradication of chronic HBV and HCV infection from the country by 2020
- Greater provision of medical training in hepatology
- A national campaign led by NHS England to increase awareness of liver disease in the general population
Cancer Genetics in Clinical Practice
A Guide to Cancer Genetics in Clinical Practice
BSG member Sue Clark has recently published a new textbook 'A GUIDE TO CANCER GENETICS IN CLINICAL PRACTICE' which has a significant gastroenterology content.
This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. It is aimed at all clinicians who may encounter these conditions in their practice. The book sets out to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.
View Flyer / Purchasing Details [ 38 Kb ]
Publication date: June 2009
BSG Guidance on Coeliac Disease 2010
The Management of Adults with Coeliac Disease
There is clear evidence that coeliac disease is a common gastrointestinal disease affecting up to 1% of the adult population. Individuals may go undetected for many years. This is despite multiple presentations to both primary and secondary care. This may reflect that fact that affected individuals have subtle gastrointestinal symptoms or no gastrointestinal symptoms.
An active case finding strategy will increase the number of patients detected with coeliac disease. Testing for coeliac disease should incorporate an IgA level, Tissue Transglutaminase antibody and/or Endomysial antibody (depending on what is locally available). In patients with a positive antibody a duodenal biopsy should be undertaken to confirm the presence of villous atrophy. In patients who are antibody negative but the clinician is suspicious then a duodenal biopsy should still be undertaken having ensured that the patient is not on a self-imposed gluten-free diet (GFD).
The cornerstone of treatment is a GFD. Patients require regular dietetic support with the opportunity or access to a gastroenterologist should further problems arise. Follow-up may be in primary or secondary care as long as the support is adequate (as noted previously).
In patients with persisting symptoms they should be investigated carefully with particular reference to ensuring that refractory coeliac disease is excluded.
Page 4 of 19